RECRUITING

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are: Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task? Participants will: Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Official Title

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, Diabetic Retinopathy (DR) and Glaucoma

Quick Facts

Study Start:2025-04-22
Study Completion:2026-12-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06593405

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Clients with AMD, DR or Glaucoma
  2. * Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.
  1. * Clients with other age related eye diseases other than AMD, DR or Glaucoma.
  2. * Clients who do not wish to participate in this study.

Contacts and Locations

Study Contact

Michelle Dowling, OTD
CONTACT
508-373-5851
michelle.dowling@mcphs.edu

Principal Investigator

Michelle Dowling, OTD
PRINCIPAL_INVESTIGATOR
MCPHS University

Study Locations (Sites)

MCPHS 10 Lincoln Square
Worcester, Massachusetts, 01608
United States

Collaborators and Investigators

Sponsor: MCPHS University

  • Michelle Dowling, OTD, PRINCIPAL_INVESTIGATOR, MCPHS University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-22
Study Completion Date2026-12-05

Study Record Updates

Study Start Date2025-04-22
Study Completion Date2026-12-05

Terms related to this study

Additional Relevant MeSH Terms

  • Age-Related Macular Degeneration